0000899243-21-019166.txt : 20210511
0000899243-21-019166.hdr.sgml : 20210511
20210511202916
ACCESSION NUMBER: 0000899243-21-019166
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210511
FILED AS OF DATE: 20210511
DATE AS OF CHANGE: 20210511
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ENRIGHT PATRICK G
CENTRAL INDEX KEY: 0001253886
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40384
FILM NUMBER: 21913120
MAIL ADDRESS:
STREET 1: CO LONGITUDE CAPITAL PARTNERS LLC
STREET 2: 800 EL CAMINO REAL, SUITE 220
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tammenoms Bakker Juliet
CENTRAL INDEX KEY: 0001431159
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40384
FILM NUMBER: 21913119
MAIL ADDRESS:
STREET 1: LONGITUDE CAPITAL MANAGEMENT CO., LLC
STREET 2: 800 EL CAMINO REAL, SUITE 220
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Longitude Venture Partners III, L.P.
CENTRAL INDEX KEY: 0001674099
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40384
FILM NUMBER: 21913121
BUSINESS ADDRESS:
STREET 1: 800 EL CAMINO REAL, SUITE 220
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-845-5700
MAIL ADDRESS:
STREET 1: 800 EL CAMINO REAL, SUITE 220
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Longitude Capital Partners III, LLC
CENTRAL INDEX KEY: 0001713663
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40384
FILM NUMBER: 21913122
BUSINESS ADDRESS:
STREET 1: 800 EL CAMINO, SUITE 220
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-845-5700
MAIL ADDRESS:
STREET 1: 800 EL CAMINO, SUITE 220
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Talaris Therapeutics, Inc.
CENTRAL INDEX KEY: 0001827506
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 201 E. JEFFERSON ST., SUITE 110B
CITY: LOUISVILLE
STATE: KY
ZIP: 40202
BUSINESS PHONE: 502-569-1059
MAIL ADDRESS:
STREET 1: 201 E. JEFFERSON ST., SUITE 110B
CITY: LOUISVILLE
STATE: KY
ZIP: 40202
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-05-11
0
0001827506
Talaris Therapeutics, Inc.
TALS
0001713663
Longitude Capital Partners III, LLC
C/O LONGITUDE CAPITAL PARTNERS III, LLC
2740 SAND HILL ROAD, 2ND FLOOR
MENLO PARK
CA
94025
0
0
1
0
0001674099
Longitude Venture Partners III, L.P.
2740 SAND HILL ROAD, 2ND FLOOR
MENLO PARK
CA
94025
0
0
1
0
0001253886
ENRIGHT PATRICK G
2740 SAND HILL ROAD, 2ND FLOOR
MENLO PARK
CA
94025
0
0
1
0
0001431159
Tammenoms Bakker Juliet
2740 SAND HILL ROAD, 2ND FLOOR
MENLO PARK
CA
94025
0
0
1
0
Common Stock
2021-05-11
4
C
0
2985775
A
2985775
I
By Longitude Venture Partners III, L.P.
Common Stock
2021-05-11
4
P
0
235000
17.00
A
3220775
I
By Longitude Venture Partners III, L.P.
Series A Preferred Stock
2021-05-11
4
C
0
1308410
0.00
D
Common Stock
1308410
0
I
By Longitude Venture Partners III, L.P.
Series A-1 Preferred Stock
2021-05-11
4
C
0
1271027
0.00
D
Common Stock
1271027
0
I
By Longitude Venture Partners III, L.P.
Series B Preferred Stock
2021-05-11
4
C
0
406338
0.00
D
Common Stock
406338
0
I
By Longitude Venture Partners III, L.P.
Each share of Series A Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series A-1 Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. Each share of Series B Preferred Stock converted into common stock on a 1-for-5.35 basis automatically upon the closing of the Issuer's initial public offering. The Series A Preferred Stock, Series A-1 Preferred Stock and Series B Preferred Stock had no expiration date.
These shares are held by Longitude Venture Partners III, L.P ("LVP III"). Longitude Capital Partners III, LLC ("LCP III") is the general partner of LVP III and may be deemed to have voting and investment power over the shares held by LVP III. Patrick G. Enright and Juliet Tammenoms Bakker are managing members of LCP III and may be deemed to share voting and investment power with respect to the shares held by LVP III. Each of LCP III, Mr. Enright and Ms. Tammenoms Bakker disclaims beneficial ownership of such shares and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.
On May 11, 2021, LVP III purchased 235,000 shares of Common Stock of the Issuer at a price of $17.00 per share pursuant to an underwritten public offering.
/s/ Patrick G. Enright, individually, and as Managing Member of Longitude Capital Partners III, LLC and as Managing Member of Longitude Capital Partners III, LLC., General Partner of Longitude Venture Partners III, L.P.
2021-05-11
/s/ Juliet Tammenoms Bakker
2021-05-11